glp-1 market size 2025 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Size
Description
These medications, originally developed for type 2 diabetes management, produce substantial weight loss partly through central nervous system mechanisms, though most glucose-lowering effects occur through peripheral actions
10.1146/annurev-pathol-020117-043617 19
However, there are still a few outstanding questions concerning the underlying mechanisms, including a detailed assessment of the gastrointestinal vagal (and probably spinal) afferences mediating GLP-1 effects at a central level to elucidate the functions of each subset of neurons associated with specific regulatory process
Miki, T
